BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 26872637)

  • 1. The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children.
    Englund A; Molin D; Enblad G; Karlén J; Glimelius I; Ljungman G; Amini RM
    Eur J Haematol; 2016 Nov; 97(5):430-438. PubMed ID: 26872637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma.
    Adam M; Bekuretsion Y; Gebremedhin A; Kwiecinska A; Howe R; Petros B; Jerkeman M
    J Clin Exp Hematop; 2023; 63(4):230-239. PubMed ID: 38148013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of IgG4-positive plasma cell population in classic Hodgkin lymphoma.
    Guler B; Tekden BC; Cetin G; Yildiz P; Turna S; Uysal O; Sinal I
    J Hematop; 2023 Dec; 16(4):191-197. PubMed ID: 38175429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.
    Johnston RL; Mottok A; Chan FC; Jiang A; Diepstra A; Visser L; Telenius A; Gascoyne RD; Friedman DL; Schwartz CL; Kelly KM; Scott DW; Horton TM; Steidl C
    Blood; 2022 Feb; 139(6):889-893. PubMed ID: 34662378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophils and mast cells: a lineage apart.
    Sarrazin S; Sieweke MH
    Nat Immunol; 2016 May; 17(6):609-11. PubMed ID: 27196510
    [No Abstract]   [Full Text] [Related]  

  • 6. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
    Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C
    Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic large cell lymphoma in paediatric and young adult patients.
    Turner SD; Lamant L; Kenner L; Brugières L
    Br J Haematol; 2016 May; 173(4):560-72. PubMed ID: 26913827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic marginal zone lymphoma: from genetics to management.
    Arcaini L; Rossi D; Paulli M
    Blood; 2016 Apr; 127(17):2072-81. PubMed ID: 26989207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.
    Rosenberg AS; Klein AK; Ruthazer R; Evens AM
    Am J Hematol; 2016 Jun; 91(6):560-5. PubMed ID: 26928381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women's Health Study.
    Prizment AE; Vierkant RA; Smyrk TC; Tillmans LS; Lee JJ; Sriramarao P; Nelson HH; Lynch CF; Thibodeau SN; Church TR; Cerhan JR; Anderson KE; Limburg PJ
    Mod Pathol; 2016 May; 29(5):516-27. PubMed ID: 26916075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.
    Batlle-López A; González de Villambrosía S; Francisco M; Malatxeberria S; Sáez A; Montalban C; Sánchez L; Garcia J; González-Barca E; López-Hernández A; Ruiz-Marcellan MC; Mollejo M; Grande C; Richards KL; Hsi ED; Tzankov A; Visco C; Xu-Monette ZY; Cao X; Young KH; Piris MÁ; Conde E; Montes-Moreno S
    Oncotarget; 2016 Apr; 7(14):18036-49. PubMed ID: 26910115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
    Lee WJ; Moon IJ; Lee SH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.
    Moench L; Sachs Z; Aasen G; Dolan M; Dayton V; Courville EL
    Leuk Lymphoma; 2016 Nov; 57(11):2626-35. PubMed ID: 26892631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis.
    Liu X; Li X; Wei H; Liu Y; Li N
    Front Immunol; 2023; 14():1209056. PubMed ID: 37497234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma.
    Casagrande N; Borghese C; Aldinucci D
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.
    Fereydouni M; Motaghed M; Ahani E; Kafri T; Dellinger K; Metcalfe DD; Kepley CL
    Front Oncol; 2022; 12():830199. PubMed ID: 35433433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications.
    Hirahara N; Matsubara T; Kaji S; Uchida Y; Hyakudomi R; Yamamoto T; Takai K; Sasaki Y; Kawakami K; Tajima Y
    Oncotarget; 2022; 13():183-197. PubMed ID: 35079325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
    Honoré B; Andersen MD; Wilken D; Kamper P; d'Amore F; Hamilton-Dutoit S; Ludvigsen M
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Roles of Mast Cells in the Regulation of Lymphatic Immuno-Physiology.
    Pal S; Nath S; Meininger CJ; Gashev AA
    Front Immunol; 2020; 11():1234. PubMed ID: 32625213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.